News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Valliant John
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/09/2023 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Granted 500,000 options to buy
@ $3.75, valued at
$1.9M
|
|
| 04/27/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 2,036 shares
@ $6.03, valued at
$12.3k
Sold 2,147 shares
@ $6.07, valued at
$13k
Sold 4,511 shares
@ $6.03, valued at
$27.2k
|
|
| 04/22/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 367 shares
@ $6.02, valued at
$2.2k
Sold 922 shares
@ $6.01, valued at
$5.5k
|
|
| 04/13/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 2,600 shares
@ $7.37, valued at
$19.2k
Sold 18,255 shares
@ $7.1, valued at
$129.6k
Sold 11,994 shares
@ $6.41, valued at
$76.9k
|
|
| 04/08/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 100 shares
@ $7.58, valued at
$758
Sold 1,255 shares
@ $7.56, valued at
$9.5k
Sold 826 shares
@ $7.52, valued at
$6.2k
|
|
| 04/05/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 1,000 shares
@ $7.75, valued at
$7.8k
Sold 700 shares
@ $7.81, valued at
$5.5k
Sold 2,100 shares
@ $7.67, valued at
$16.1k
|
|
| 04/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 500 shares
@ $7.42, valued at
$3.7k
Sold 9,600 shares
@ $7.55, valued at
$72.5k
Sold 200 shares
@ $7.52, valued at
$1.5k
|
|
| 03/24/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 4,000 shares
@ $7.53, valued at
$30.1k
Sold 100 shares
@ $7.5, valued at
$750
Sold 700 shares
@ $7.46, valued at
$5.2k
|
|
| 03/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 12,600 shares
@ $8.33, valued at
$105k
Sold 33,202 shares
@ $7.99, valued at
$265.3k
Sold 1,700 shares
@ $7.98, valued at
$13.6k
|
|
| 02/08/2021 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Granted 336,000 options to buy
@ $11.9, valued at
$4M
|
|
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
3
| Valliant John (CEO) has filed a Form 3 on Fusion Pharmaceuticals Inc. |
|
|